4094. A Transcriptomic-Based Tool to Predict Gemcitabine Sensitivity in Advanced Pancreatic Adenocarcinoma.
作者: Nicolas Fraunhoffer.;Brice Chanez.;Carlos Teyssedou.; .;Juan L Iovanna.;Emmanuel Mitry.;Nelson J Dusetti.
来源: Gastroenterology. 2023年164卷3期476-480.e4页 4095. Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
作者: Paola Nicoletti.;Andrew Dellinger.;Yi Ju Li.;Huiman X Barnhart.;Naga Chalasani.;Robert J Fontana.;Joseph A Odin.;Jose Serrano.;Andrew Stolz.;Amy S Etheridge.;Federico Innocenti.;Olivier Govaere.;Jane I Grove.;Camilla Stephens.;Guruprasad P Aithal.;Raul J Andrade.;Einar S Bjornsson.;Ann K Daly.;M Isabel Lucena.;Paul B Watkins.; .; .; .
来源: Gastroenterology. 2023年164卷3期454-466页
Drug-induced liver injury (DILI) due to amoxicillin-clavulanate (AC) has been associated with HLA-A∗02:01, HLA-DRB1∗15:01, and rs2476601, a missense variant in PTPN22. The aim of this study was to identify novel risk factors for AC-DILI and to construct a genetic risk score (GRS).
4099. Race and Ethnicity, Stage-Specific Mortality, and Cancer Treatment in Esophageal and Gastric Cancers: Surveillance, Epidemiology, and End Results (2000-2018).
作者: Omonefe O Omofuma.;Michael B Cook.;Christian C Abnet.;M Constanza Camargo.
来源: Gastroenterology. 2023年164卷3期473-475.e4页 |